|
Index of reports
> All Cases (1729)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to PEG-Intron (Peginterferon Alfa-2B) all cases. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 1729 Next >>
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-27
Patient:
Reactions: Rash
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 microgram per kilogram, unk
Start date: 2012-06-19
Rebetol
Dosage: 600 mg, unk
Administration route: Oral
Start date: 2012-06-19
Rebetol
Dosage: 400 mg, unk
Administration route: Oral
Start date: 2012-07-03
Telavic
Dosage: 2250 mg, unk
Administration route: Oral
Start date: 2012-06-19
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-27
Patient:
Reactions: Anaemia, Blood Uric Acid Increased, Decreased Appetite
Drug(s) suspected as cause:
PEG-Intron
Dosage: 30 microgram per kilogram, qw
Start date: 2012-07-05
PEG-Intron
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-06-14
End date: 2012-06-21
PEG-Intron
Dosage: 50 microgram per kilogram, qw
Start date: 2012-07-12
PEG-Intron
Dosage: 70 microgram per kilogram, qw
Start date: 2012-07-19
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-14
End date: 2012-06-27
Rebetol
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-07-05
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-14
End date: 2012-06-27
Other drugs received by patient: Theo-DUR; Lendormin; Mucodyne
Possible PEG-Intron side effects in
Reported by a physician from United States on 2012-08-27
Patient:
Reactions: Exposure VIA Father
Drug(s) suspected as cause:
PEG-Intron
Possible PEG-Intron side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-27
Patient: female
Reactions: Dehydration, Anaemia, Lower Respiratory Tract Inflammation
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2012-02-15
Ribavirin
Dosage: unk
Indication: Hepatitis C
Start date: 2012-02-15
VX-950
Dosage: 750 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-15
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27
Patient:
Reactions: Myalgia, Injection Site Haemorrhage, Nausea, Chills, Sinus Headache, Hyperhidrosis, Muscle Spasms
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2012-07-22
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2012-07-22
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from Japan on 2012-08-27
Patient:
Reactions: Malaise, Renal Impairment, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 microgram per kilogram, unk
Indication: Hepatitis C
Start date: 2012-06-06
Rebetol
Dosage: 600 mg, unk
Administration route: Oral
Start date: 2012-06-15
End date: 2012-06-20
Rebetol
Dosage: 200 mg, unk
Administration route: Oral
Start date: 2012-06-21
End date: 2012-07-12
Rebetol
Dosage: 800 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-06
End date: 2012-06-14
Rebetol
Dosage: 200 mg, qod
Administration route: Oral
Start date: 2012-07-13
Telavic
Dosage: 1500 mg, unk
Administration route: Oral
Start date: 2012-06-08
Telavic
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-06
End date: 2012-06-07
Other drugs received by patient: Lendormin; Lansoprazole; Amoban
Possible PEG-Intron side effects in
Reported by a physician from United States on 2012-08-27
Patient:
Reactions: Gingival Pain, Glossodynia, Stomatitis, LIP Pain
Drug(s) suspected as cause:
PEG-Intron
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-27
Patient:
Reactions: Interstitial Lung Disease, Oedema, Hepatic Failure
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Bactrim
Dosage: 1 df, once
Administration route: Oral
Indication: Adverse Event
End date: 2012-06-09
PEG-Intron
Dosage: 1.5mcg/kg/week
Indication: Hepatitis C
Start date: 2012-03-13
End date: 2012-04-04
Rebetol
Dosage: 800 mg, once
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-13
End date: 2012-04-04
Telavic
Dosage: 2250 mg, once
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-13
End date: 2012-04-04
Other drugs received by patient: Urso 250; Lasix; Celestamine TAB; NEO-Minophagen C; Aldactone
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from Japan on 2012-08-27
Patient:
Reactions: Drug Eruption, Haemoglobin Decreased, Malaise, Hyperglycaemia, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-05-17
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-17
End date: 2012-06-13
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-06-14
End date: 2012-06-28
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Start date: 2012-07-18
End date: 2012-07-26
Telavic
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-17
End date: 2012-05-25
Telavic
Dosage: 2250 mg, qd
Administration route: Oral
Other drugs received by patient: Motilium; Gasmotin; Diflorasone Diacetate; Nizatidine
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from United States on 2012-08-27
Patient:
Reactions: Headache
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2012-07-16
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2012-07-17
Victrelis
Dosage: unk
Indication: Hepatitis C
Start date: 2012-08-12
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-27
Patient:
Reactions: Rash
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-05-07
Rebetol
Dosage: 200 mg, unk
Administration route: Oral
Start date: 2012-06-25
End date: 2012-07-30
Rebetol
Dosage: 400 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-07
End date: 2012-06-24
Telavic
Dosage: 1500 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-07
End date: 2012-07-08
Other drugs received by patient: Loxonin; Olopatadine HCL; Allopurinol; Betamethasone Sodium Phosphate
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-27
Patient:
Reactions: Anaemia
Drug(s) suspected as cause:
Antiviral (Unspecified)
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-04
PEG-Intron
Dosage: 1.5 ?g/kg, qw
Indication: Hepatitis C
Ribavirin
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-02-08
Ribavirin
Dosage: 800 mg, qd
Administration route: Oral
Indication: Hepatitis C
End date: 2012-02-07
Other drugs received by patient: Lorfenamin; Livalo; Epadel S; Claritin Reditabs; Sodium Ferrous Citrate
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from Japan on 2012-08-27
Patient:
Reactions: Platelet Count Decreased
Drug(s) suspected as cause:
PEG-Intron
Dosage: 100 microgram, qw
Start date: 2012-05-02
End date: 2012-05-02
PEG-Intron
Dosage: 40 microgram, qw
Start date: 2012-06-06
End date: 2012-06-20
PEG-Intron
Dosage: 50 microgram, qw
Start date: 2012-04-18
End date: 2012-04-18
PEG-Intron
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-04-11
End date: 2012-04-11
PEG-Intron
Dosage: 30 microgram,
Start date: 2012-06-27
End date: 2012-06-27
PEG-Intron
Dosage: 75 microgram, qw
Start date: 2012-04-25
End date: 2012-04-25
PEG-Intron
Dosage: 50 microgram, qw
Start date: 2012-05-09
End date: 2012-05-30
PEG-Intron
Dosage: 40 microgram, unk
Start date: 2012-07-04
Rebetol
Dosage: 800 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-11
Telavic
Dosage: 1.5 g, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-11
End date: 2012-04-14
Telavic
Dosage: 1.5 g, qd
Administration route: Oral
End date: 2012-06-27
Telavic
Dosage: unk
Administration route: Oral
Start date: 2012-04-17
Other drugs received by patient: Glycyron; Talion (Bepotastine Besylate); Loxonin; Loxonin; Urso 250; NEO-Minophagen C; Motilium
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27
Patient:
Reactions: Liver Injury, Viral Load Increased, Drug Ineffective
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2009-01-01
End date: 2010-01-01
Pegasys
Dosage: unk
Start date: 2012-06-28
End date: 2012-08-02
Pegasys
Dosage: unk
Indication: Hepatitis C
Start date: 2010-01-01
End date: 2011-01-01
Rebetol
Dosage: unk
Start date: 2012-06-28
End date: 2012-08-02
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2010-01-01
End date: 2011-01-01
Telaprevir
Dosage: unk
Indication: Hepatitis C
Start date: 2012-06-28
End date: 2012-08-02
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from Japan on 2012-08-27
Patient:
Reactions: Malaise
Drug(s) suspected as cause:
PEG-Intron
Dosage: 100 microgram per kilogram, unk
Indication: Hepatitis C
Start date: 2012-06-15
End date: 2012-07-13
Rebetol
Dosage: 800 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-15
Rebetol
Dosage: 400 mg, unk
Administration route: Oral
Start date: 2012-07-06
End date: 2012-07-13
Telavic
Dosage: 2250 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-15
Telavic
Dosage: 1500 mg, unk
Administration route: Oral
Start date: 2012-07-06
End date: 2012-07-13
Other drugs received by patient: Diflunisal; Januvia; Basen
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-27
Patient:
Reactions: Renal Impairment, Anaemia, Pancreatitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-04-27
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-27
End date: 2012-05-24
Rebetol
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-05-25
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-27
End date: 2012-05-17
Other drugs received by patient: Antebate; Prednisolone; Dexaltin; Ubiron; Aspara CA; Loxonin; Onealfa; Diovan; Berizym (Lysozyme Chloride); Mirobect; Amlodipine; Isoleucine (+) Leucine (+) Valine; Lansoprazole; Mucosta
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from Japan on 2012-08-27
Patient:
Reactions: White Blood Cell Count Decreased, Renal Impairment, Anaemia, Platelet Count Decreased, Decreased Appetite
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 mcg /kg/week
Indication: Hepatitis C
Start date: 2012-04-13
End date: 2012-04-25
PEG-Intron
Dosage: 1.0 mcg /kg/week
Start date: 2012-06-26
PEG-Intron
Dosage: 1.0 mcg /kg/week
Start date: 2012-04-26
End date: 2012-06-06
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-13
End date: 2012-06-06
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-06-26
Telavic
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-13
End date: 2012-06-07
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Start date: 2012-06-26
End date: 2012-07-24
Other drugs received by patient: Motilium; Lorfenamin; Motilium; L Cartin; Rikkunshi-TO; Epadel
Possible PEG-Intron side effects in 59 year old female
Reported by a physician from Canada on 2012-08-27
Patient: 59 year old female, weighing 44.0 kg (96.8 pounds)
Reactions: Oesophageal Varices Haemorrhage, Ascites
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Incivek
Dosage: 750 mg, tid
Administration route: Oral
Indication: Hepatitis C
PEG-Intron
Dosage: 120 unk, unk
Indication: Hepatitis C
Other drugs received by patient: Nadolol; Lasix; Atenolol; Spironolactone; Eprex
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from United States on 2012-08-27
Patient:
Reactions: Irritability, Fatigue
Drug(s) suspected as cause:
PEG-Intron
Dosage: 150 ?g, qw
Indication: Hepatitis C
Start date: 2012-05-16
Ribavirin
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Orgasuline Rapide; Antiviral (Unspecified)
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-27
Patient:
Reactions: Nausea
Drug(s) suspected as cause:
PEG-Intron
Dosage: 80 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-06-12
End date: 2012-06-17
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-12
End date: 2012-06-17
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-12
End date: 2012-06-17
Other drugs received by patient: Talion (Bepotastine Besylate); Mucosta; Loxonin
Possible PEG-Intron side effects in
Reported by a physician from United States on 2012-08-27
Patient:
Reactions: Product Quality Issue, NO Adverse Event, Underdose
Drug(s) suspected as cause:
PEG-Intron
Possible PEG-Intron side effects in
Reported by a physician from United States on 2012-08-27
Patient:
Reactions: Product Quality Issue, Abdominal Discomfort, Malaise, Pneumonia, Nasopharyngitis, Vomiting, Bronchitis, Cough
Drug(s) suspected as cause:
PEG-Intron
Other drugs received by patient: Lisinopril; Seroquel
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from Japan on 2012-08-27
Patient:
Reactions: Anaemia
Drug(s) suspected as cause:
PEG-Intron
Dosage: 0.8 microgram per kilogram, qw
Start date: 2012-05-08
PEG-Intron
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-04-18
End date: 2012-04-24
PEG-Intron
Dosage: 1.0 microgram per kilogram, qw
Start date: 2012-05-01
End date: 2012-05-01
Rebetol
Dosage: 800 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-18
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-18
End date: 2012-07-12
Other drugs received by patient: Claritin; Ferotym; Livalo; Epadel S
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from United States on 2012-08-27
Patient:
Reactions: Haemoglobin Decreased, Dysgeusia, Nausea, Chills, Asthenia
Drug(s) suspected as cause:
PEG-Intron
Dosage: 80 microgram, qw
Rebetol
Dosage: unk
Administration route: Oral
Victrelis
Dosage: unk
Administration route: Oral
Other drugs received by patient: Protonix
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-27
Patient:
Reactions: Generalised Erythema
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 microgram per kilogram, unk
Indication: Hepatitis C
Rebetol
Dosage: 800 mg, unk
Administration route: Oral
Start date: 2012-05-08
End date: 2012-05-14
Rebetol
Dosage: 400 mg, unk
Administration route: Oral
Start date: 2012-05-15
Rebetol
Dosage: 1000 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-24
End date: 2012-05-07
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Start date: 2012-07-03
End date: 2012-07-05
Telavic
Dosage: 2250 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-24
End date: 2012-06-11
Other drugs received by patient: Norvasc; Rinderon V; Allopurinol; Hirudoid; Xyzal; Allopurinol; Prednisolone; Rabeprazole Sodium; Rabeprazole Sodium; [composition Unspecified]; Clobetasol Propionate; Sitagliptin Phosphate
Possible PEG-Intron side effects in
Reported by a individual with unspecified qualification from Germany on 2012-08-27
Patient:
Reactions: Maternal Exposure Before Pregnancy, Abortion Induced
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis
End date: 2012-01-01
Rebetol
Dosage: unk
End date: 2012-01-01
Victrelis
Dosage: 200 mg, qd
Indication: Hepatitis
Start date: 2012-01-09
End date: 2012-05-01
Other drugs received by patient: Lexotanil
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27
Patient:
Reactions: White Blood Cell Count Decreased, Contusion, Anaemia, Fall, Loss of Consciousness, Haemoglobin Decreased, Anxiety, Dysgeusia, Urine Uric Acid Increased, Disturbance in Attention, Injury, Feeling Abnormal, Asthenia
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-03-03
Rebetol
Dosage: unk unk, qam
Indication: Hepatitis C
Start date: 2012-03-03
Rebetol
Dosage: unk unk, qpm
Rebetol
Dosage: unk unk, qam
Rebetol
Dosage: unk unk, qpm
Start date: 2012-03-03
Rebetol
Dosage: unk unk, qpm
Rebetol
Dosage: unk unk, qam
Victrelis
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-03-31
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from United States on 2012-08-27
Patient:
Reactions: Injection Site Erythema, Nasal Dryness, Epistaxis
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2012-07-16
Rebetol
Dosage: unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-07-16
Victrelis
Dosage: unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-08-20
Possible PEG-Intron side effects in
Reported by a physician from United States on 2012-08-27
Patient:
Reactions: Fatigue, Nausea, Headache
Drug(s) suspected as cause:
PEG-Intron
Dosage: 150 microgram, qw
Rebetol
Administration route: Oral
Other drugs received by patient: Zyrtec; Lisinopril; Nortriptyline HCL; Atenolol; Prilosec; Estradiol
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from Japan on 2012-08-27
Patient:
Reactions: Psychiatric Symptom
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-02-21
End date: 2012-03-16
Rebetol
Dosage: cumulative dose: 20000 mg
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-21
End date: 2012-03-13
Rebetol
Dosage: cumulative dose: 20000 mg
Administration route: Oral
Start date: 2012-03-13
End date: 2012-03-16
Telavic
Dosage: cumulative dose: 56250 mg
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-21
End date: 2012-03-16
Other drugs received by patient: Loxoprofen; Allopurinol
Page 1 Next >>
|
